KINIKSA PHARMACEUTICALS INTL

Ticker: KNSA CUSIP: G52694109 Class: Common Stock

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's Holding History (CIK: 0001132716)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 37,602 Value ($000) $1,040 Avg Close $25.46 Range $18.25 - $30.69

Q1 2025

Shares 139,275 Value ($000) $3,093 Avg Close $20.58 Range $17.82 - $24.31

Q4 2024

Shares 99,632 Value ($000) $1,971 Avg Close $22.82 Range $19.47 - $28.15

Q3 2024

Shares 75,169 Value ($000) $1,878 Avg Close $24.36 Range $17.38 - $27.92

Q2 2024

Shares 113,995 Value ($000) $2,128 Avg Close $18.73 Range $16.56 - $20.52

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	37,602	$1,040	$25.46	$18.25 - $30.69
Q1 2025	139,275	$3,093	$20.58	$17.82 - $24.31
Q4 2024	99,632	$1,971	$22.82	$19.47 - $28.15
Q3 2024	75,169	$1,878	$24.36	$17.38 - $27.92
Q2 2024	113,995	$2,128	$18.73	$16.56 - $20.52